These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2169923)

  • 21. Construction, expression, and characterization of a chimera of factor IX and factor X. The role of the second epidermal growth factor domain and serine protease domain in factor Va binding.
    Hertzberg MS; Ben-Tal O; Furie B; Furie BC
    J Biol Chem; 1992 Jul; 267(21):14759-66. PubMed ID: 1634519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
    Astermark J; Stenflo J
    J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-probed conformational transitions in the protease domain of human factor IX upon calcium binding and zymogen activation: putative high-affinity Ca(2+)-binding site in the protease domain.
    Bajaj SP; Sabharwal AK; Gorka J; Birktoft JJ
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):152-6. PubMed ID: 1729682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A moderate form of hemophilia B is caused by a novel mutation in the protease domain of factor IXVancouver.
    Geddes VA; Le Bonniec BF; Louie GV; Brayer GD; Thompson AR; MacGillivray RT
    J Biol Chem; 1989 Mar; 264(8):4689-97. PubMed ID: 2494175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of functionally important residues of the epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis. Residues Asn(89)-Gly(93) are critical for binding factor VIIIa.
    Chang YJ; Wu HL; Hamaguchi N; Hsu YC; Lin SW
    J Biol Chem; 2002 Jul; 277(28):25393-9. PubMed ID: 11960977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The connecting segment between both epidermal growth factor-like domains in blood coagulation factor IX contributes to stimulation by factor VIIIa and its isolated A2 domain.
    Celie PH; Van Stempvoort G; Fribourg C; Schurgers LJ; Lenting PJ; Mertens K
    J Biol Chem; 2002 Jun; 277(23):20214-20. PubMed ID: 11925427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. Evidence for defects affecting the latent catalytic site.
    Usharani P; Warn-Cramer BJ; Kasper CK; Bajaj SP
    J Clin Invest; 1985 Jan; 75(1):76-83. PubMed ID: 3965513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of the EGF-like domain mutations Pro55Ser and Pro55Leu, which cause mild hemophilia B.
    Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Stenflo J; Ljung RC
    J Thromb Haemost; 2003 Apr; 1(4):782-90. PubMed ID: 12871416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence-specific 1H NMR assignments, secondary structure, and location of the calcium binding site in the first epidermal growth factor like domain of blood coagulation factor IX.
    Huang LH; Cheng H; Pardi A; Tam JP; Sweeney WV
    Biochemistry; 1991 Jul; 30(30):7402-9. PubMed ID: 1854745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.
    Rees DJ; Jones IM; Handford PA; Walter SJ; Esnouf MP; Smith KJ; Brownlee GG
    EMBO J; 1988 Jul; 7(7):2053-61. PubMed ID: 3262057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. Importance of helix 330 (helix 162 in chymotrypsin) of protease domain of factor IXa in its interaction with factor VIIIa.
    Mathur A; Bajaj SP
    J Biol Chem; 1999 Jun; 274(26):18477-86. PubMed ID: 10373456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.
    Bajaj SP
    Thromb Haemost; 1999 Aug; 82(2):218-25. PubMed ID: 10605707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein engineering of the hydrophobic domain of human factor IX.
    Hughes PE; Handford PA; Austen DE; Brownlee GG
    Protein Eng; 1994 Sep; 7(9):1121-7. PubMed ID: 7831283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity.
    Celie PH; Lenting PJ; Mertens K
    J Biol Chem; 2000 Jan; 275(1):229-34. PubMed ID: 10617609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of residues Asn89, Ile90, and Val107 of the factor IXa second epidermal growth factor domain that are essential for the assembly of the factor X-activating complex on activated platelets.
    Yang X; Chang YJ; Lin SW; Walsh PN
    J Biol Chem; 2004 Nov; 279(45):46400-5. PubMed ID: 15328360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the first growth factor domain of human factor IXa in binding to platelets and in factor X activation.
    Ahmad SS; Rawala-Sheikh R; Cheung WF; Stafford DW; Walsh PN
    J Biol Chem; 1992 Apr; 267(12):8571-6. PubMed ID: 1569103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.
    Wu PC; Hamaguchi N; Yu YS; Shen MC; Lin SW
    Thromb Haemost; 2000 Oct; 84(4):626-34. PubMed ID: 11057861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
    Chang JY; Monroe DM; Stafford DW; Brinkhous KM; Roberts HR
    J Clin Invest; 1997 Aug; 100(4):886-92. PubMed ID: 9259588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canine hemophilia B resulting from a point mutation with unusual consequences.
    Evans JP; Brinkhous KM; Brayer GD; Reisner HM; High KA
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10095-9. PubMed ID: 2481310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in the catalytic domain of factor IX that are related to the subclass hemophilia Bm.
    Hamaguchi N; Roberts H; Stafford DW
    Biochemistry; 1993 Jun; 32(25):6324-9. PubMed ID: 8518277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.